Features of this month's Journal
Angiotensin II dose–effect curves and Schild regression plots for characterization of different angiotensin II AT1 receptor antagonists in clinical pharmacology
Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma
Population pharmacokinetics of intramuscular gentamicin administered to young infants with suspected severe sepsis in Kenya
Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin–clarithromycin interaction
Lack of pharmacokinetic interaction between retigabine and phenobarbitone at steady-state in healthy subjects
A population pharmacokinetic model for paclitaxel in the presence of a novel P-gp modulator, Zosuquidar Trihydrochloride (LY335979)
Physiologically based modelling of inhibition of metabolism and assessment of the relative potency of drug and metabolite
CYP2D6, GST-M1 and GST-T1 enzymes
Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population
Discontinuation and switching of therapy after initiation of lipid-lowering drugs
Antibiotic prescribing for children. Too much and too little? Retrospective observational study in primary care
Development of a dosing strategy for enoxaparin in obese patients
Add-on therapy with montelukast or formoterol in patients with the glycine-16 β2-receptor genotype
Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus
The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6
Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves
Single-dose pharmacokinetics and tolerability of pegylated interferon-α2b in young and elderly healthy subjects
Comparability of whole-blood and plasma clozapine and norclozapine concentrations